Get started
AAA

AROA BIOSURGERY LIMITED

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

ARX chart


Full chart

ARX upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪225.91 M‬ AUD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.030 AUD
Net income (FY)
‪−9.85 M‬ AUD
Revenue (FY)
‪64.02 M‬ AUD
Shares float
‪227.43 M‬
Beta (1Y)
0.19

About AROA BIOSURGERY LIMITED


Sector
Health Technology
Industry
Medical Specialties
CEO
Brian Roderick Ward
Website
aroa.com
Headquarters
Mangere
Founded
2008
ISIN
NZARXE0001S1
FIGI
BBG00VX929P6
Aroa Biosurgery Ltd. engages in the development, manufacturing, and marketing of soft tissue repair products. It focuses on healing for complex wounds, and soft tissue reconstruction procedures including abdominal wall reconstruction, breast reconstruction, and reconstructive surgery for trauma, limb salvage, and tumor resections. The company was founded by Brian Roderick Ward in 2008 and is headquartered in Mangere, New Zealand.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

ARX news



Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of ARX is 0.655 AUD — it has increased by 0.77% in the past 24 hours. Watch AROA BIOSURGERY LIMITED stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on ASX exchange AROA BIOSURGERY LIMITED stocks are traded under the ticker ARX.
ARX stock has risen by 3.97% compared to the previous week, the month change is a 10.08% rise, over the last year AROA BIOSURGERY LIMITED has showed a −2.24% decrease.
We've gathered analysts' opinions on AROA BIOSURGERY LIMITED future price: according to them, ARX price has a max estimate of 1.05 AUD and a min estimate of 0.70 AUD. Watch ARX chart and read a more detailed AROA BIOSURGERY LIMITED stock forecast: see what analysts think of AROA BIOSURGERY LIMITED and suggest that you do with its stocks.
ARX reached its all-time high on Jul 30, 2020 with the price of 1.745 AUD, and its all-time low was 0.440 AUD and was reached on Aug 22, 2024. View more price dynamics on ARX chart.
See other stocks reaching their highest and lowest prices.
ARX stock is 1.54% volatile and has beta coefficient of 0.19. Track AROA BIOSURGERY LIMITED stock price on the chart and check out the list of the most volatile stocks — is AROA BIOSURGERY LIMITED there?
Today AROA BIOSURGERY LIMITED has the market capitalization of ‪225.91 M‬, it has increased by 3.17% over the last week.
Yes, you can track AROA BIOSURGERY LIMITED financials in yearly and quarterly reports right on TradingView.
AROA BIOSURGERY LIMITED is going to release the next earnings report on Nov 26, 2024. Keep track of upcoming events with our Earnings Calendar.
ARX earnings for the last half-year are −0.01 AUD per share, whereas the estimation was 0.00 AUD, resulting in a −300.00% surprise. The estimated earnings for the next half-year are −0.01 AUD per share. See more details about AROA BIOSURGERY LIMITED earnings.
AROA BIOSURGERY LIMITED revenue for the last half-year amounts to ‪34.09 M‬ AUD, despite the estimated figure of ‪33.73 M‬ AUD. In the next half-year revenue is expected to reach ‪35.88 M‬ AUD.
ARX net income for the last half-year is ‪−4.02 M‬ AUD, while the previous report showed ‪−5.83 M‬ AUD of net income which accounts for 31.11% change. Track more AROA BIOSURGERY LIMITED financial stats to get the full picture.
No, ARX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. AROA BIOSURGERY LIMITED EBITDA is ‪−7.36 M‬ AUD, and current EBITDA margin is −11.50%. See more stats in AROA BIOSURGERY LIMITED financial statements.
Like other stocks, ARX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade AROA BIOSURGERY LIMITED stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So AROA BIOSURGERY LIMITED technincal analysis shows the strong buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating AROA BIOSURGERY LIMITED stock shows the neutral signal. See more of AROA BIOSURGERY LIMITED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.